Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy

Journal of Cardiovascular Electrophysiology

Volumn 18, Issue 12, 2007, Pages 1236-1240

  Cardinalli Neto, Augusto ^a   Bestetti, Reinaldo B ^a   Cordeiro, José A ^a   Rodrigues, Vanessa C ^a  

^a HOSPITAL DE BASE   (Brazil)

Author keywords

Arrhythmias; Chagas; Disease; Implantable cardioverter defibrillators; Shock; Sudden death

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; METOPROLOL; PROPRANOLOL DERIVATIVE;

ADULT; ARTICLE; CAUSE OF DEATH; CHAGAS DISEASE; CONTROLLED STUDY; DEFIBRILLATOR; DISEASE SEVERITY; ELECTROGRAPHY; EXTRACORPOREAL LITHOTRIPSY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART ASSIST DEVICE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PACING; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; SUDDEN DEATH; TREATMENT FAILURE;

BRAZIL; CHAGAS CARDIOMYOPATHY; CHRONIC DISEASE; COMORBIDITY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR;

EID: 36148946820     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2007.00954.x     Document Type: Article

References (26)

1. Dias JCP, Silveira AC, Shofield CJ : The impact of Chagas' disease control in Latin América. A review. Mem Inst Oswaldo Cruz 2002 97 : 603 612.
2. Bestetti RB, Rossi MA : A rationale approach for mortality risk stratification in Chagas' disease. Int J Cardiol 1997 58 : 199 209.
3. Bestetti RB, Freitas OC, Muccillo G, Oliveira JSM : Clinical and morphological characteristics associated with sudden cardiac death in patients with Chagas' disease. Eur Heart J 1993 14 : 1610 1614.
4. Bestetti RB, Dalbo CMR, Arruda CA, Correia-Filho D, Freitas OC : Predictors of sudden cardiac death for patients with Chagas' disease: A hospital-derived cohort study. Cardiology 1996 87 : 481 487.
5. Rabinovich R, Muratore C, Iglesias R, Gonzales M, Daru M, Valentino M, Liprandi AR, Luceri R : Time to first shock in implantable cardioverter defibrillator patients with Chagas' cardiomyopathy. PACE 1999 22 : 202 205.
6. Cardinalli-Neto A, Greco OT, Bestetti RB : Automatic implantable cardioverter defibrillators in Chagas' heart disease patients with malignant ventricular arrhythmias. PACE 2006 29 : 467 470.
7. Sternick EB, Martinelli-Filho M, Sampaio R, Gerken LM, Teixeira RA, Scarpelli R, Scanavacca M, Nishioka SD, Sosa E : Sudden cardiac death in patients with Chagas' heart disease and preserved left ventricular function. J Cardiovasc Electrophysiol 2006 17 : 113 116.
8. Dubner S, Valero E, Pesce R, Zuelgaray JG, Mateos JCP, Galvão-Filho S, Reyes W, Garillo R : A Latin American registry of implantable cardioverter defibrillators: The ICD-LABOR study. Ann Noninvas Electrocardiol 2005 10 : 420 428.
9. Exner DV, Klein GJ : Do we need a randomized trial of defibrillator therapy in every subset of patients with increased risk of sudden death? J Cardiovasc Electrophysiol 2003 14 : 574 577.
10. Verma S, Kilcaslan F, Marrouche NF, Minor S, Khan Mohammed, Wazni O, Burkhardt JD, Belden WA, Cummings JE, Karim AA, Saliba W, Schweikert RA, Tchou PJ, Martin DO, Natale A : Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm. J Cardiovasc Electrophysiol 2004 15 : 1265 1270.
11. Zipes D, Roberts D : Results of the international study of the implantable pacemaker-cardioverter-defibrillator: Comparison of epicardial lead systems. Circulation 1995 92 : 59 65.
12. Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH : Electrical storm in patients with tranvenous implantable cardioverter- defibrillators: Incidence, management and prognostic implications. J Am Coll Cardiol 1998 32 : 1909 1915.
13. Villacastin J, Almendral J, Arenal A, Albertos J, Ormaetxe J, Peinado R, Bueno H, Merino JL, Pastor A, Medina O, Tercedor L, Jimenez F, Delcan JL : Incidence and clinical significance of multiple consecutive, appropriate, high-energy discharges in patients with implantable cardioverter-defibrillators. Circulation 1996 93 : 753 762.
14. Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, Thorpe K, Champagne J, Talajic M, Coutu B, Gronefield GC, Hohnloser SH : Comparison of B-Blockers, amiodarone plus B-Blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators. J Am Med Assoc 2006 295 : 165 171.
15. Sosa E, Scanavacca M, D'Ávila A, Bellotti G, Pileggi F : Radiofrequency catheter ablation of ventricular tachycardia guided by nonsurgical epicardial mapping in chronic chagasic heart disease. Pacing Clin Electrophysiol 1999 22 : 128 130.
16. Bestetti RB, Santos CRF, Machado Jr. OB, Ariolli MT, Carmo JL, Costa NK, Oliveira RB : Clinical profile of patients with Chagas' disease before and during ventricular tachycardia. Int J Cardiol 1990 29 : 39 46.
17. Desai AS, Fang JC, Maisel WH, Baughman KL : Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy. J Am Med Assoc 2004 292 : 2874 2879.
18. Gatzoulis KA, Andrikopoulos GK, Apostolopoulos T, Satiropoulos E, Zervopoulos G, Antoniou J, Brili S, Stefanadis CI : Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy. Europace 2005 7 : 184 192.
19. Brigadeau F, Kouakam C, Klug D, Marquié C, Duhamel A, Mizon-Gerard F, Lacroix D, Kacet S : Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators. Eur heart J 2006 27 : 700 707.
20. Connolly SJ : Use and misuse of surrogate outcomes in arrhythmia trials. Circulation 2006 113 : 764 766.
21. Ellenbogen KA, Levine JH, Berger RD, Daubert JP, Winters SL, Greenstein E, Shalaby A, Schaechter A, Subacius H, Kadish A : Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 2006 113 : 776 782.
22. Bestetti RB : Role of parasites in the pathogenesis of Chagas' cardiomyopathy. Lancet 1996 347 : 913 914.
23. Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, Daubert JP, McNitt S, Andrews ML, Elkin AD : Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004 110 : 3760 3765.
24. Epstein AE, Kay GN, Plumb VJ, Dailey SM, Anderson PG : Gross and microscopic pathological changes associated with nonthoracotomy implantable defibrillators leads. Circulation 1998 98 : 1517 1525.
25. Germano JJ, Reynolds M, Essebag V, Josephson ME : Frequency and causes of implantable cardioverter-defibrillator therapies: Is device therapy proarrhythmic? Am J Cardiol 2006 97 : 1255 1261.
26. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin KJ : Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter defibrillators. Circulation 2004 110 : 2591 2596.